Grant Williams, MD
Grant Williams, MD is an oncology and regulatory consultant. He received his medical and oncology training at the University of Alabama in Birmingham prior to joining FDA in 1989. For 16 years, from 1989 to 2005, he worked in the Division of Oncology Drug Products at FDA evaluating cancer drug applications, 8 years as a medical reviewer, 5 years as a medical team leader and 3 years as Deputy Director. During his tenure at FDA he contributed to 3 guidance documents, including the Cancer Endpoints Guidance. He subsequently spent three and half years working in oncology clinical development with Novartis and GSK. In September 2008 he became an independent based in Wayne, PA. Over the past 9 years he has worked as a consultant exclusively in oncology regulatory strategy.
